Viet Nam approves emergency use of Cuba-made Abdala vaccine
VGP - The Ministry of Health has listed Cuba’s Abdala COVID-19 vaccine for emergency use in Viet Nam.
 |
|
The Ministry of Health approves the emergency use of Cuba’s Abdala COVID-19 vaccine in Viet Nam. |
The vaccine is developed by the Center for Genetic Engineering and Biotechnology (CIGB) and has an efficacy rate of 92.28 percent in three doses administered at 14-day intervals.
Last month, the Cuban Center for State Control of Medicines, Equipment and Medical Devices granted emergency use authorization to Abdala in Cuba.
Abdala becomes the eighth foreign COVID-19 vaccine approved for emergency use in Viet Nam aside from the U.K.’s AstraZeneca, the U.S.’s Johnson & Johnson, Moderna and Pfizer-BioNTech, Russia’s Sputnik V, China’s Sinopharm and the UAE’s Hayat-Vax.
The Southeast Asian nation has received around 36 million COVID-19 vaccine doses through contracts, Government aid and COVAX facility. As of September 17, more than 33 million doses were administered, with 6,184,726 having been fully vaccinated./.
By Thuy Dung
